跳至主要内容
临床试验/IRCT201510251598N3
IRCT201510251598N3已完成3 期

Comparing effect of tizanidine hydrochloride vs. placebo on muscle cramp in hemodialysis patients in

Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 99 years(—)
性别
All

入选标准

  • At least 18 year old; give informed consent to participate in the 2 month clinical trial; at least has once weekly muscle cramp episode during previous month; stable hemodialysis patients and no hypotension during muscle cramp episode (Systolic BP=90 mmHg); chronic hemodialysis patients for at least 3 months; serum calcium level= 8.3 mg/dL;
  • serum sodium level= 135 mEq/L
  • Exclusion criteria:
  • side effect appearing to tizanidine; any time patient wishes to exit from the study.

排除标准

  • 未提供

研究者

发起方
Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences

相似试验

Comparing effect of tizanidine hydrochloride vs.... | 临床试验